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ABSTRACT
Objectives To review systematically current literature on
kidney function changes during pregnancy, in order to
estimate the extent of adaptation over the course of both
healthy physiological and complicated singleton preg-
nancies, and to determine healthy pregnancy reference
values.
Methods PubMed (NCBI) and EMBASE (Ovid) elec-
tronic databases were searched, from inception to July
2017, for studies on kidney function during uncompli-
cated and complicated pregnancies. Included studies were
required to report a non-pregnant reference value of kid-
ney function (either in a non-pregnant control group or
as a prepregnancy or postpartum measurement) and a
pregnancy measurement at a predetermined and reported
gestational age. Kidney function measures assessed were
glomerular filtration rate (GFR) measured by inulin clear-
ance, GFR measured by creatinine clearance and serum
creatinine level. Pooled mean differences between preg-
nancy measurements and reference values were calculated
for predefined intervals of gestational age in uncompli-
cated and complicated pregnancies using a random-effects
model described by DerSimonian andLaird.
Results Twenty-nine studies met the inclusion criteria
and were included in the analysis. As early as the first
trimester, GFR was increased by up to 40–50% in phys-
iological pregnancy when compared with non-pregnant
values. Inulin clearance in uncomplicated pregnancy was
highest at 36–41weeks, with a 55.6% (53.7; 95%
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CI, 44.7–62.6mL/min) increase when compared with
non-pregnant values, and creatinine clearance was high-
est at 15–21weeks’ gestation, with a 37.6% (36.6;
95% CI, 26.2–46.9mL/min) increase. Decrease in serum
creatinine level in uncomplicated pregnancy was most
prominent at 15–21weeks, with a 23.2% (−0.19; 95%
CI, −0.23 to −0.15mg/dL) decrease when compared
with non-pregnant values. Eight studies reported on
pregnancies complicated by a hypertensive disorder.
Meta-regression analysis showed a significant difference in
all kidney function parameters when comparing uncom-
plicated and hypertensive complicated pregnancies.
Conclusions In healthy pregnancy, GFR is increased
as early as the first trimester, as compared with
non-pregnant values, and the kidneys continue to function
at a higher rate throughout gestation. In contrast, kidney
function is decreased in hypertensive pregnancy. © 2018
The Authors. Ultrasound in Obstetrics & Gynecology
published by John Wiley & Sons Ltd on behalf of the
International Society of Ultrasound in Obstetrics and
Gynecology.
INTRODUCTION
Decreased vascular resistance is thought to induce
adaptations that occur during normal physiological
pregnancy and are sustained by increased nitric oxide
production1,2. Decrease in resistance initiates a chain of
events that results in a rise in cardiac output and abets the
expansion of plasma volume by stimulating renal sodium
© 2018 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd SYSTEMATIC REVIEW
on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.
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and water retention, sodium appetite and thirst3. Both
increased renal blood flow and decreased oncotic pressure
due to plasma volume expansion contribute to higher
glomerular filtration rate (GFR)4,5.
In humans, this increase in GFR is reported as
early as the first weeks after conception and is usually
sustained until the end of gestation, but reported
data show considerable individual variation6. Pregnancy
complicated by hypertensive disease shows decreased
kidney function. Despite this knowledge, reference curves
of kidney function in pregnancy are lacking in the
literature7,8. This meta-analysis therefore aimed to review
and quantify systematically current literature on kidney
function, as assessed by GFR or serum creatinine (SC),
during pregnancy in order to estimate the extent of
adaptation over the course of both physiological and
complicated singleton pregnancy. We also aimed to
construct references curves for GFR and SC level in
healthy pregnancy, defining the 5th, 50th and 95th
percentiles.
METHODS
Literature search
PubMed (NCBI) and EMBASE (Ovid) were searched,
from inception to July 2017, for studies evaluating kidney
function in physiological uncomplicated and hypertensive
complicated pregnancies. The search strategy focused
on pregnancy, both uncomplicated and complicated,
and kidney function (Table S1). Complicated pregnancy
was subdivided into pregnancy-induced hypertension,
fetal growth restriction (FGR), pre-eclampsia (PE) and
gestational diabetes mellitus (GDM). All components
consisted of free search terms in titles and abstracts
and MeSH and Emtree terms for PubMed and EMBASE
databases, respectively. Reference lists of all included
studies were searched manually for additional studies.
Selection of studies
Studies were assessed for inclusion following a two-phased
selection process (Figure 1). First, all obtained articles
were screened independently for eligibility by two
investigators (V.L.vB., T.vG.) based on title and abstract
only. Discrepancies were resolved by mutual agreement.
Subsequently, the full-text version of articles that passed
the first selection phase were read and screened, based
on the inclusion and exclusion criteria, by the same
investigators.
Studies were eligible for inclusion if they reported
original data, including mean GFR, estimated GFR
(eGFR) or SC in human singleton pregnancy, with
either SD, standard error (SE) or 95% CI. We assumed
that values were normally distributed. Studies were
required to include a reference value from non-pregnant
controls or from the study women themselves, either
prepregnancy or postpartum (> 6 weeks). This was
relevant in order to be able to calculate differences
between pregnancy and reference measurements within
each study. Additionally, there were no restrictions
on age, weight, height, ethnicity or parity. Exclusion
criteria were: assessment of women with comorbidity
(such as pre-existing cardiovascular history, diabetes
mellitus, kidney disease and immunological disease) and
language other than English, Dutch, Spanish, Italian,
Portuguese, French or German. Case reports and reviews
were also excluded. Measurements obtained following an
intervention were not used, but baseline measurements in
an intervention study were9–12.
Data extraction
Data regarding study characteristics, anthropometric
measures and methods used to measure (e)GFR and SC
were extracted from the selected studies. Regarding study
characteristics, the following were obtained: authors, year
of publication, study design, sample size, population
description, inclusion and exclusion criteria and key
conclusions.
Extracted patient and pregnancy characteristics con-
sisted of age, non-pregnant weight and body mass index,
height, parity, gravidity, body surface area, gestational
age at (e)GFR or SC measurement, birth weight and
gestational age at delivery. For women with a gesta-
tional hypertensive disease, gestational age at onset of
the hypertensive disorder was documented. Effect mea-
sures included eGFR, GFR and SC as primary outcomes,
and heart rate, systolic blood pressure, diastolic blood
pressure and mean arterial pressure as secondary out-
comes. We defined GFR as kidney function measured by
either inulin or creatinine clearance (mL/min) and eGFR
as kidney function measured by any formula based on
SC (mL/min/1.73m2 or mL/min). Data on GFR measure-
ment protocol, eGFR formulae and SC analysis were also
extracted. If a study contained more than one measure-
ment during the predefined gestational age intervals, the
mean value was calculated13,14. Additional information
from the authors of the included articles was requested if
data were unclear or incomplete.
Quality assessment
The quality and risk of bias of included studies were
assessed independently by two investigators (V.A.L.v.B.,
T.A.G.v.G.) according to a modified set of items reported
in the Quality in Prognosis Study (QUIPS) tool15. This
modification was made to suit the purposes of this review.
A plus, minus or question mark (which counts as a
minus and was used when follow-up was not applicable)
was allocated for each study in each of the five risk of bias
domains, including study participation, study attrition,
variable measurement, data reporting and study design.
All domains were deemed of equal importance and thus
weighted accordingly in the total score. Studies with a pos-
itive score of ≥ 60% were defined as high quality (HQ),
those scoring ≥ 30% and < 60% as moderate quality
(MQ) and those scoring <30% as low quality (LQ).
© 2018 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2019; 54: 297–307.
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Figure 1 Flowchart summarizing selection, inclusion and exclusion in systematic review of studies on kidney function in pregnancy.
Data and statistical analysis
(e)GFR and SC were categorized into five different
intervals of gestational age (7–14, 15–21, 22–28, 29–35
and 36–41 weeks). These intervals were adapted from
Abudu et al.16. SD was obtained from SE or 95% CI and
calculated for combined groups according to the Cochrane
Handbook for Systematic Review of Interventions,
when necessary17. Change in (e)GFR and SC was
calculated according to these predefined intervals using a
random-effects model, as described by DerSimonian and
Laird18. The random-effects model allows for interstudy
variation and was chosen by design as observational
data on different pregnant populations were used. The
primary outcome of each study was mean difference in
(e)GFR and SC between pregnancy and reference values,
reported with 95% CI. The relative increase or decrease
from reference was reported as percentage (95% CI).
Reference values in healthy pregnancy were constructed
by plotting the mean of the reference (non-pregnant)
measurements in each study, at each gestational age
and time postpartum. Because different laboratory
methods were used to measure serum creatinine, we
evaluated the effect of measurement type in regression
analysis.
The 5th and 95th percentiles were calculated from
intrastudy variance as 95% prediction intervals. Each
point estimate was indexed as a value from a LQ, MQ
or HQ study, as determined during quality assessment.
The meta-analyses and meta-regression analyses were
performed in R version 3.2.3 using the meta package
V4.8-419,20. The results of the meta-analysis are presented
in forest plots.
The ratio between total heterogeneity and total
variability (I-squared statistic; I2) was computed as
a measure of heterogeneity. I2 can distinguish true
heterogeneity from sampling variance and is expressed as
a percentage21. Sources of heterogeneity were investigated
by meta-regression analyses using a mixed-effects model.
Egger’s regression test for funnel plot asymmetry was
performed to test for the presence of publication bias22.
RESULTS
Study and data selection
The literature search identified 10 160 potentially eligible
articles in PubMed and EMBASE after removal of dupli-
cates (Figure 1). No additional articles were found in the
manual search of reference lists. Of these studies, 176
were eligible for full-text assessment after screening based
on title and abstract. We excluded 147 full text articles
for several reasons, a large number of which were due
to unobtainable data (n= 74; Figure 1 and Appendix S1).
No studies were excluded based on language. Contact-
ing authors did not result in any additional information.
Finally, 29 studies were included, constituting 20 precon-
ception, 376 non-pregnant, 1037 healthy pregnant, 204
© 2018 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2019; 54: 297–307.
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hypertensive complicated pregnancies and 246 postpar-
tum kidney function values.
Three studies, two of which are included in this
review and analysis, contained eGFR values23–25; all other
studies reported GFR measured by either inulin (GFR-IC)
or creatinine (GFR-CC) clearance. We were therefore
unable to perform a meta-analysis of eGFR. Three
studies contained values of inulin clearance expressed
as mL/min/1.73m2, which we were unable to process in
this meta-analysis due to body surface area data not being
provided26–28.
Two studies13,29 reported repeat measurements during
the predefined intervals; mean and SD were calculated
for these studies, ignoring potential clustering. In a study
containing 398 healthy pregnant participants, a total of
six women developed PE in late pregnancy; these women
were not excluded from statistical analysis in the study,
or from the current meta-analysis, due to the marginal
effect it may be expected to have on the results30. Because
our meta-analysis showed a significant difference between
GFR measured by inulin and GFR measured by creatinine
clearance (P<0.001), these were analyzed separately.
Data extraction
Eight studies included women with hypertensive compli-
cated pregnancy, namely gestational hypertension31 and
PE31–38. We found no studies describing women with
GDM. Study characteristics and anthropometric measures
are illustrated in Tables 1 and 2 for uncomplicated preg-
nancies and those complicated by a hypertensive disease,
respectively. For most studies, the overall characteristics
are detailed. Anthropometric data were reported infre-
quently and incompletely. It was therefore not possible to
analyze the contribution of these variables to the observed
heterogeneity. Tables S2–S4 illustrate for each study the
measurement methods used for GFR-IC, GFR-CC and SC.
Quality assessment
Quality assessment of the included studies is detailed
in Table S5. Most (n= 15) studies were of MQ, whilst the
remainder were of HQ (n= 9) or LQ (n= 5). Quality
scores varied between 12% and 82% (median 53%;
interquartile range 41–65%).
The modified QUIPS criterion, ‘the methods and setting
are the same for all study participants and throughout
follow-up’ was met by all studies, while the items with
the fewest studies scoring positively were ‘baseline value
was a prepregnant measurement of the variable’ (n= 2),
‘multiple (> 2) longitudinal measurements during preg-
nancy of the variable’ (n= 5) and ‘adequate description
of participant’s ethnicity characteristics’ (n= 7).
Glomerular filtration rate: inulin clearance
Forest plots illustrating mean difference in GFR-IC
in uncomplicated pregnancies compared with refer-
ence values, according to gestational age, are shown
in Figure S1. GFR-IC, when compared to reference
values, was increased during uncomplicated pregnancy
at all gestational age intervals, with a mean differ-
ence (95% CI) of 40.7 (14.1–67.3) mL/min and relative
increase (95% CI) of 37.7% (13.1–62.4%) at<14 weeks,
47.8 (35.1–60.6) mL/min and 46.6% (34.2–59.1%)
at 15–21 weeks, 44.8 (29.2–60.4) mL/min and 40.2%
(26.2–54.1%) at 22–28 weeks, 39.6 (27.1–52.1) mL/min
and 35.6% (24.4–46.8%) at 29–35 weeks and 53.7
(44.7–62.6) mL/min and 55.6% (46.3–64.9%) at
36–41 weeks. Meta-regression analysis showed no sig-
nificant effect of gestational age on GFR-IC (P= 0.789).
In terms of study-level covariates, to interpret het-
erogeneity a significant statistical association between
GFR-IC and the type of reference measurement (postpar-
tum vs non-pregnant, P= 0.001; there were no prepreg-
nancy measurements) and between GFR-IC and study
quality (MQ vs HQ, P= 0.036; there was only one LQ
study and its effect could therefore not be calculated)
was found. Eggers’s funnel plot asymmetry could not
be calculated for < 14 weeks due to a lack of studies
but was not statistically significant at any other interval
(0.254< P< 0.721).
Two included studies reported data on GFR-IC in
pregnancies complicated by a hypertensive disorder at
29–35 weeks and at 36–41 weeks (Figure S2). In contrast
to uncomplicated pregnancies, a significant mean decrease
(95% CI) in GFR-IC of −62.4 (−75.9 to −48.9) mL/min
and relative decrease (95% CI) of −51.2% (−62.3 to
−40.2%) was seen at 29–35 weeks and no effect was seen
at 36–41 weeks (−3.0 (−8.7 to 2.7) mL/min and −3.3%
(−9.5 to 3.0%)), as compared with reference values. These
results differed significantly from those in uncomplicated
pregnancies (P< 0.001).
Reference values for GFR-IC in physiological uncom-
plicated pregnancy are presented in Figure 2; there was
an overall increase during pregnancy and a slight decrease
after 28 weeks of gestation.
Glomerular filtration rate: creatinine clearance
Forest plots of mean difference in GFR-CC in uncom-
plicated pregnancies compared with reference val-
ues, according to gestational age, is illustrated
in Figure S3. When compared with reference values,
GFR-CC was increased significantly throughout uncom-
plicated pregnancy. GFR-CC increased progressively
until 15–21 weeks of gestation, with a mean differ-
ence (95% CI) of 22.0 (9.9–34.0) mL/min and relative
increase of 23.7% (10.7–36.7%) at < 14 weeks and
36.6 (26.2–46.9) mL/min and 37.6% (26.9–48.2%) at
15–21 weeks. At 22–28 weeks of gestation, GFR-CC
was still increased by 28.7 (16.8–40.6) mL/min and
26.9% (15.7–38.0%), and by 16.0 (9.1–22.9) mL/min
and 15.1% (8.6–21.7%) at 29–35 weeks, but this was
to a lesser extent than at previous gestational age inter-
vals. GFR-CC was decreased at 36–41 weeks of gestation
(−8.8 (−54.4 to 36.8) mL/min and −8.0% (−49.6 to
33.5%)), but this was not significant.
© 2018 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2019; 54: 297–307.
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Table 1 Characteristics of included studies on kidney function in uncomplicated pregnancy
Parity (n)
Non-pregnant
Subjects Age Weight Height
(n) (years) (kg) (cm) Nulli- Primi- Multi-
Study R P R P R P R P R P R P R P Ref GA (w) Methods
Abdul-Karim
(1978)52
20 91 — — — — — — — — — — — — NP 16, 26, 33,
37
SC
Ahmed (2009)23 12 12 — — 65 65 164 164 — — — — — — PP (15 w) 21, 34 GFR (IC and
24h CC), SC
Akram (1982)53 30 29 28.5 29.7 — — — — — — — — — — NP 39, 10 PP GFR (24h CC),
SC
Barden (1996)32 24 28 27.3 26.8 — — — — — — — 13 — 15 NP 30 GFR (24h CC)
Barron (1995)54 22 22 28.7 28.7 — — — — — — — — — — PP (44 w) 30 GFR (IC and
24h CC)
Buttermann
(1958)33
11 72 — — — — — — — — — — — — NP 11, 23, 35 GFR (IC and
24h CC)
Chapman
(1998)13
11 10 30.9 30.9 61.5 — — — 9 — — — — — PC 12, 24, 36 SC
Davison
(1974)12
10 10 28.7 28.7 56.1 56.1 160 160 — — 3 3 7 7 PP (10 w) 17, 27, 37 GFR (IC and
24h CC)
Davison
(1981)29
9 9 26.4 26.4 58.6 58.6 162 162 2 2 7 7 — — PC 14, 16 GFR (24h CC),
SC
Davison
(1980)55
10 10 — — 61.8 61.8 164 164 — — 3 3 7 7 PP (10 w) 26 GFR (24h CC)
Dunlop
(1975)56
18 18 — — — — — — — — — — — — PP (8 w) 37 GFR (IC)
Dunlop
(1981)57
25 25 28.6 28.6 62.8 62.8 163 163 — — 10 10 15 15 PP (8 w) 16, 26, 36 GFR (IC)
Gibson (1973)58 9 9 28.1 28.1 56.4 56.4 157 157 — — 7 7 2 2 PP (12 w) 20, 28 GFR (IC)
Irons (1996)9 12 12 — — — — — — — — 12 12 — — PP (16 w) 32 GFR (IC)
Kristensen
(2007)30
58 398 25.0 32.0 — — — — 49 177 — — — — NP 10, 25, 35,
40
SC
Lohsiriwat
(2008)59
26 26 25.1 25.1 63.1 63.1 — — — — — — — — PP (9 w) 34 GFR (24h CC),
SC
Milne (2002)10 11 11 27.1 27.1 — — — — — — — — — — PP (16 w) 37 GFR (IC), SC
Moran (2003)34 13 13 — — — — — — — — — — — — PP (20 w) 37 GFR (IC)
Mozdzien
(1995)60
11 15 23.0 23.0 — — 164 164 — — 6 6 9 9 PP (8 w) 10, 24, 33 GFR (24h CC),
SC
Roberts
(1996)61
11 11 31.0 31.0 — — 164 164 6 6 — — — — PP (16 w) 16, 36 GFR (IC), SC
Saxena (2012)62 12 12 28.7 28.7 — — 163 164 — — — — — — PP (16 w) 22, 34 GFR (IC and
24h CC), SC
Schneider
(1996)35
6 16 23.5 28.5 — — — — — — 0 11 — — NP 33 GFR (24h CC)
Smith (2008)25 23 24 — — — — — — — — — — — — PP (8 w) 13, 36 GFR (IC)
Strevens
(2002)31
12 14 27.0 30.0 58.8 — 168 163 — — — — — — NP 33 SC
Sturgiss
(1996)11
7 7 31.0 31.0 63.3 63.3 159 159 — — — — — — PP (22 w) 18, 35 GFR (IC)
Vural (1998)36 15 20 — — — — — — — 20 — — — — NP 32 GFR (24h CC),
SC
Wang (1994)37 26 42 27.0 29.0 — — — — — — — — — — NP 34 GFR (24h CC)
Wright (1987)63 9 31 — — — — — — — — 17 17 — — PP (6 w) 14, 28, 36 GFR (2h CC)
Yilmaz (2017)38 40 40 27.6 26.0 — — — — — — — — — — NP 34 GFR (24h CC),
SC
First author only given for each study. Continuous variables are given as means. CC, creatinine clearance; GA, gestational age at
measurement; GFR, glomerular filtration rate; IC, inulin clearance; NP, non-pregnant control; P, physiological pregnancies;
PC, prepregnancy; PP, postpartum; R, reference pregnancies; Ref, reference measurement; SC, serum creatinine; w, weeks.
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Table 2 Characteristics of included studies on kidney function in pregnancy complicated by hypertensive disorder
Parity (n)
Non-pregnant
Subjects Age Weight Height
(n) (years) (kg) (cm) Nulli- Primi- Multi-
Study R CP R CP R CP R CP R CP R CP R CP Ref GA (w) Methods
Barden (1996)32 24 20 27.3 27.4 — — — — — — — 9 — 11 NP 30 GFR (24h CC)
Buttermann
(1958)33
11 33 — — — — — — — — — — — — NP 35 GFR (IC and
24h CC)
Moran (2003)34 5 10 — — — — — — — — — — — — PP (20 w) 37 GFR (IC)
Schneider
(1996)35
6 16 23.5 28.6 — — — — — — 0 11 — — NP 33 GFR (CC*)
Strevens
(2002)31
12 24 27.0 31.0 58.8 — 168 164 — — — — — — NP 36 SC
Vural (1998)36 15 24 — — — — — — — 24 — — — — NP 33 GFR (24h CC),
SC
Wang (1994)37 26 37 27.0 27.0 — — — — — — — — — — NP 36 GFR (24h CC)
Yilmaz (2017)38 40 40 27.6 27.9 — — — — — — — — — — NP 35 GFR (24h CC),
SC
First author only given for each study. Continuous variables are given as means. *Hours not reported. CC, creatinine clearance; CP, hyper-
tensive complicated pregnancies; GA, gestational age at measurement; GFR, glomerular filtration rate; IC, inulin clearance; NP, non-
pregnant control; PP, postpartum; R, reference pregnancies; Ref, reference measurement; SC, serum creatinine; w, weeks.
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Meta-regression analysis showed a significant associa-
tion between GFR-CC and gestational age (P= 0.007),
however, in contrast to GFR-IC, no significant effect
was seen according to the type of reference measurement
(pre-pregnant vs non-pregnant, P= 0.227; postpartum vs
non-pregnant, P= 0.811). There was an effect of MQ vs
HQ studies (P= 0.01) but no effect of LQ vs HQ stud-
ies (P= 0.07) on GFR-CC. Egger’s test for funnel plot
asymmetry found no indication of publication bias at any
gestational age interval (0.344<P< 0.697).
Six included studies reported data on GFR-CC in
pregnancies complicated by hypertension (Figure S4).
In these pregnancies, GFR-CC showed a significant
decrease of −14.7 (95% CI, −22.1 to −7.3) mL/min
and a relative decrease of −14.1% (95% CI, −21.2 to
−7.1%) at 29–35 weeks of gestation when compared
to reference measurements. This value was significantly
different when compared to healthy pregnancy values at
the same gestational age interval (P= 0.008).
Figure 3 shows reference values for GFR-CC through-
out physiological uncomplicated pregnancy. There is an
increase in GFR-CC until around 16 weeks of gestation
and a decrease thereafter. After 24 weeks, the hetero-
geneity between studies increased, as can be seen by the
number of studies outside the reference curves estimated
using aggregated data.
Serum creatinine
Forest plots of mean difference in SC in uncomplicated
pregnancies compared with reference values, according
to gestational age, is illustrated in Figure S5. Throughout
uncomplicated pregnancy, SC is decreased in comparison
to non-pregnant reference conditions. At <14 weeks’
gestation, SC was decreased slightly, with a mean
difference (95% CI) of −0.12 (−0.15 to −0.08) mg/dL
and a relative difference (95% CI) of −16.5% (−20.4 to
−14.0%) and was decreased further at 15–21 weeks, with
a mean difference of −0.19 (−0.23 to −0.15) mg/dL and
relative difference of −23.2% (−28.1 to −18.3%), only
to reach a plateau at 22–28 weeks with −0.18 (−0.22
to −0.15) mg/dL and −22.6% (−27.7 to −18.9%). At
29–35 weeks, SC reached its lowest difference compared
to reference values, at −0.12 (−0.15 to −0.10) mg/dL
and −15.5% (−19.4 to −13.0%), which then increased
almost to non-significance with a mean difference of
−0.14 (−0.27 to −0.02) mg/dL and relative difference
of −17.7% (−34.2 to −2.5%) at the end of pregnancy.
The meta-regression analysis showed that there was
no effect of gestational age on SC (P= 0.687) or of
the type of reference measurement (pre-pregnant vs
non-pregnant, P= 0.553; postpartum vs non-pregnant,
P= 0.641) or study quality (LQ vs HQ, P= 0.578; MQ
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vs HQ, P= 0.157). There was also no effect of the
laboratory measurement method on the regression curve.
Egger’s regression test for funnel plot asymmetry was not
statistically significant (0.108<P< 0.919).
Studies with data on SC in pregnancies complicated by
hypertension (Figure S6) reported measurements at 29–35
and 36–41 weeks’ gestation. In contrast to uncomplicated
pregnancies, there was no change in SC in women with a
complicated pregnancy, as compared to non-pregnant
values. Mean difference (95% CI) was 0.15 (−0.03
to 0.32) mg/dL and relative difference (95% CI) was
21.2% (−4.2 to 45.2%) at 29–35 weeks’ gestation, with
−0.01 (−0.16 to 0.15) mg/dL and −1.4% (−23.2 to
21.7%) at 36–41 weeks. These values were, however,
significantly different from those in uncomplicated
pregnancy (P= 0.009).
Reference values for SC throughout physiological
uncomplicated pregnancy are shown in Figure 4 and
demonstrate a decrease during pregnancy until around
24 weeks’ gestation, after which it increases almost back
to non-pregnant values. The upper range of the reference
curve changes throughout gestation, but a cut-off can be
set at 0.75 mg/dL (66 μmol/L) based on the upper limit
for the gestational age at which SC is at its highest during
pregnancy. In Figures S7–S9, forest plots and reference
curves for SC are available in μmol/L.
DISCUSSION
Kidney function, quantified by GFR measured either
by inulin clearance or creatinine clearance, was increased
during healthy uncomplicated pregnancy as compared
with non-pregnant values. The physiological change
in kidney function was not observed in women
with a gestational hypertensive disease. Interestingly,
the GFR increase seemed slightly less than that
reported previously39. We found the largest increase
during pregnancy to be 40–50%, depending on the
method of GFR measurement. SC values were decreased
during healthy uncomplicated pregnancy as compared
with non-pregnant values. Although the upper limit
of the reference curve changes throughout gestation,
from a clinical perspective, SC above 0.75 mg/dL
(66 μmol/L) should be considered abnormal at all
gestational ages.
GFR can be measured by the renal clearance of
different substances. The ideal marker is a solute that
is non-toxic, freely filtered and neither secreted nor
reabsorbed by the kidney tubules. Despite the clinical
importance of GFR, quantifying it is not without its
difficulties. Multiple endogenous and exogenous filtration
markers have been used to evaluate kidney function40.
Inulin is the most commonly used exogenous marker
and is considered the gold standard, while creatinine is
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the most clinically used endogenous marker. Measuring
GFR through inulin has the disadvantages of being
a time-consuming and complex procedure. Infusion
protocols that use dextrose may be valid but usually
overestimate GFR values due to hyperglycemia. This may
be particularly relevant during pregnancy as maternal
insulin resistance increases glucose availability41. The
use of extra volume by infusion of saline, which is
sometimes done when measuring GFR with inulin, can
also positively affect GFR due to volume expansion.
Because of the disadvantages of inulin, creatinine has
become widely accepted for measuring GFR, even though
it is less accurate. It is usually measured in a 24-h urine
collection in combination with serum creatinine to assess
creatinine clearance. Inaccuracy of creatinine clearance is
caused predominantly by the necessity to collect complete
24-h urine and the bioavailability of creatinine quantities
fluctuating as a function of dietary intake and exercise
induced muscle strain42,43. The aggregated data used
to build the GFR-CC curve show large heterogeneity
between studies, making it unfit to serve as a reference
curve. Fitting curves using flexible regression techniques
instead of a locally weighted curve, as we did to visualize
reference ranges, could result in a better fit of all studies;
it does, however, not result in a more reliable reference
curve.
eGFR is calculated by SC using different formulae
that can take several factors into account (weight, age
and ethnicity). The more commonly used formulae
are Cockcroft–Gault, Modification of Diet in Renal
Disease and the more recent Chronic Kidney Disease
Epidemiology Collaboration (CKD-EPI), but they can
vary in accuracy during pregnancy23,25,44. Noteworthy
is that all of these formulae are based on large
cohorts of non-pregnant patients with at least mild renal
insufficiency45–47.
Estimated GFR is used frequently in daily practice but
our search did not identify enough studies to include in our
meta-analysis to be able to provide an estimated difference
during pregnancy. eGFR should be calculated using the
CKD-EPI equation, the more reliable estimation outside
of pregnancy48, before, during and after pregnancy in
order to establish reference values relevant to clinicians in
daily practice.
We found differences in GFR, both in inulin and
creatinine clearance, between women with an uncom-
plicated pregnancy and those with a hypertensive com-
plication in the second half of pregnancy; this is in
agreement with the literature. The different changes in
kidney function in pregnancies destined to be compli-
cated by gestational hypertensive disease could not be
investigated because there were not enough studies for
each gestational age interval. When assuming compa-
rable body composition and glucose metabolism, lower
GFR and higher serum creatinine in gestational hyperten-
sive pregnancy may originate from several mechanisms.
First, hypertension results in an increase in arterial
tone as a result of an excess of vasoconstrictor over
vasodilator influences in the systemic circulation49,50.
Increased vascular tone in turn causes higher renal
vascular resistance which is responsible for a decrease
in blood flow through the kidneys, and therefore a
decrease in GFR51. Morphological changes in the kid-
ney caused by pre-eclampsia, namely endotheliosis, can
also result in decreased GFR. Second, it could be that some
women, because of pre-existing vulnerability (namely
fewer nephrons), women with diabetes mellitus or those
with immunological disorders are susceptible to damage
to the kidneys and, as a result, a decrease in GFR. As
measuring GFR-IC during pregnancy is cumbersome and
complex, GFR-CC is considered to be clinically more
appropriate to evaluate kidney function. However, SC
seems a reliable and stable measure with a low margin
of error when compared with GFR-CC, which is also
more discommodious for women. As SC is measured
frequently during pregnancy, it is also a more practical
parameter.
The following limitations of this study should be
acknowledged. First, our meta-analysis was based on
a relatively limited number of studies, due mostly to the
necessity of a non-pregnant reference within the studied
population sample. While this could have resulted in lower
statistical power than if studies without reference samples
had also been included, it is thought to increase validity
because of the use of identical measurement techniques.
Second, participant’s anthropometric data were often
reported incompletely, making it impossible to analyze
the contribution of these variables to the heterogeneity
observed. Third, methodological shortcomings within
and disparities between studies resulted in limited data
interpretation, which is reflected in our meta-regression
analysis that demonstrated a significant effect on the
regression when study quality was taken into account.
In MQ studies, GFR-IC was on average 10 mL/min
higher than in HQ studies and, average GFR-CC
was 22 mL/min lower compared to in HQ studies.
A significant statistical association between GFR-IC
and type of reference measurement was also found.
This association was not found for GFR-CC and is
possibly the effect of a single study that is relatively
old and of a different methodological quality than
other included articles33. Also, according to Egger, the
capacity to ascertain publication bias is restricted when
meta-analysis consists solely of limited and/or small
studies, both of which were the case in the current
systematic review.
In conclusion, in healthy uncomplicated pregnancy,
kidney function was increased throughout gestation,
reflected by increased GFR, measured by either inulin
or creatinine clearance, and a decrease in SC. In
contrast, kidney function was decreased in hypertensive
pregnancy.
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SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Appendix S1 Full-text articles excluded and reasons for exclusion
Figures S1 and S2 Forest plot of mean difference (MD) in glomerular filtration rate (GFR), measured by inulin
clearance in mL/min, in physiological uncomplicated pregnancies (Figure S1) or hypertensive complicated
pregnancies (Figure S2), as compared with non-pregnant reference value, according to gestational age.
Figures S3 and S4 Forest plot of mean difference (MD) in glomerular filtration rate, measured by creatinine
clearance, in mL/min, in physiological uncomplicated pregnancies (Figure S3) or hypertensive complicated
pregnancies at 29–35 weeks of gestation (Figure S4), as compared with non-pregnant reference value,
according to gestational age.
Figures S5 and S6 Forest plot of mean difference (MD) in serum creatinine, in mg/dL in physiological
uncomplicated pregnancies (Figure S5) or in hypertensive complicated pregnancies (Figure S6), as compared
with non-pregnant reference values, according to gestational age.
Figures S7 and S8 Forest plot of mean difference in serum creatinine, in μmol/L, in physiological pregnancies
(Figure S7) or in hypertensive complicated pregnancies (Figure S8), as compared with non-pregnant reference
value, according to gestational age.
Figure S9 Serum creatinine, in μmol/L, during physiologic pregnancy.
Table S1 Search strategy for PubMed (NCBI) and EMBASE (Ovid) databases
Table S2 Measurement methods used in studies reporting glomerular filtration rate measured by inulin
clearance
Table S3 Measurement methods used in studies reporting glomerular filtration rate measured by creatinine
clearance
Table S4 Measurement methods used in studies reporting serum creatinine
Table S5 Quality assessment of 29 included studies based on QUIPS criteria
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